Valeant says Bausch & Lomb’s over-the-counter eye drop gets FDA nod



(Reuters) – Canadian drugmaker Valeant Pharmaceuticals International Inc said the U.S. Food and Drug Administration approved Lumify drop to treat eye redness.

The eye drop, made by the company’s Bausch & Lomb eye care business, has been approved for over-the-counter sale, Valeant said.

Lumify, first approved in 1996 as a treatment for patients with glaucoma, is currently available at higher doses as a prescription medicine.

Reporting by Tamara Mathias in Bengaluru; Editing by Sriraj Kalluvila

Our Standards:The Thomson Reuters Trust Principles.



Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.